The U.S. Food and Drug Administration (FDA) is aware of a potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes.
Safety data from controlled clinical trials have shown that there is a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia.
Avandia (rosiglitazone) is manufactured by drug maker GlaxoSmithKline,
and is one of the most popular pharmaceuticals for the treatment of Type 2 Diabetes
If you or someone you know has taken Avandia
you or that someone or their family may be entitled to monetary damages.
AVANDIA LAWSUIT INFO
Subscribe to:
Post Comments (Atom)
Posts
.jpg)
No comments:
Post a Comment